Global RNAi for Therapeutic Market Data Survey Report 2025
Summary
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.
The global RNAi for Therapeutic market will reach xxx Million USD in 2017 with CAGR xx% from 2018-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers (manufacturing sites, capacity and production, product specifications etc.)
Average market price by SUK
Major applications
Key manufacturers are included based on manufacturing sites, capacity and production, product specifications etc.:
- Alnylam Pharmaceuticals
- Arrowhead
- Dicerna Pharmaceuticals
- Mirna Therapeutics
- Quark Pharmaceuticals
- RXi Pharmaceuticals
- miRagen Therapeutics
- Gradalis
- Sirnaomics
- Cancer
- Cardiovascular
- HBV
- Other
- Asia-Pacific
- North America
- Europe
- South America
- Middle East & Africa
1 GLOBAL MARKET OVERVIEW
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Alnylam Pharmaceuticals
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Arrowhead
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Dicerna Pharmaceuticals
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Mirna Therapeutics
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Quark Pharmaceuticals
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 RXi Pharmaceuticals
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 miRagen Therapeutics
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Gradalis
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Sirnaomics
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Cancer
4.1.1 Overview
4.1.2 Cancer Market Size and Forecast
4.2 Cardiovascular
4.2.1 Overview
4.2.2 Cardiovascular Market Size and Forecast
4.3 HBV
4.3.1 Overview
4.3.2 HBV Market Size and Forecast
4.4 Other
4.4.1 Overview
4.4.2 Other Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
1.1 Scope of Statistics
1.1.1 Scope of Products
1.1.2 Scope of Manufacturers
1.1.3 Scope of Application
1.1.4 Scope of Regions/Countries
1.2 Global Market Size
2 REGIONAL MARKET
2.1 Regional Production
2.2 Regional Demand
2.3 Regional Trade
3 KEY MANUFACTURERS
3.1 Alnylam Pharmaceuticals
3.1.2 Company Information
3.1.2 Product Specifications
3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.2 Arrowhead
3.2.1 Company Information
3.2.2 Product Specifications
3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.3 Dicerna Pharmaceuticals
3.3.1 Company Information
3.3.2 Product Specifications
3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.4 Mirna Therapeutics
3.4.1 Company Information
3.4.2 Product Specifications
3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.5 Quark Pharmaceuticals
3.5.1 Company Information
3.5.2 Product Specifications
3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.6 RXi Pharmaceuticals
3.6.1 Company Information
3.6.2 Product Specifications
3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.7 miRagen Therapeutics
3.7.1 Company Information
3.7.2 Product Specifications
3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.8 Gradalis
3.8.1 Company Information
3.8.2 Product Specifications
3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
3.9 Sirnaomics
3.9.1 Company Information
3.9.2 Product Specifications
3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 MAJOR APPLICATION
4.1 Cancer
4.1.1 Overview
4.1.2 Cancer Market Size and Forecast
4.2 Cardiovascular
4.2.1 Overview
4.2.2 Cardiovascular Market Size and Forecast
4.3 HBV
4.3.1 Overview
4.3.2 HBV Market Size and Forecast
4.4 Other
4.4.1 Overview
4.4.2 Other Market Size and Forecast
5 MARKET PRICE
5.1 Overview
5.2 Price by SUK
6 CONCLUSION
LIST OF TABLES
Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Alnylam Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Arrowhead
Tab Sales Revenue, Volume, Price, Cost and Margin of Dicerna Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Mirna Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Quark Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of RXi Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of miRagen Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Gradalis
Tab Sales Revenue, Volume, Price, Cost and Margin of Sirnaomics
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
Tab REGIONAL PRODUCTION 2011-2017 (VALUE)
Tab Regional Production 2011-2017 (Volume)
Tab Regional Demand and CAGR 2011-2017 (Value)
Tab Regional Demand and CAGR 2011-2017 (Volume)
Tab Regional Demand Forecast and CAGR 2018-2025 (Value)
Tab Regional Demand Forecast and CAGR 2018-2025 (Volume)
Tab Regional Export 2011-2017 (Value)
Tab Regional Export 2011-2017 (Volume)
Tab Regional Import 2011-2017 (Value)
Tab Regional Import 2011-2017 (Volume)
Tab Sales Revenue, Volume, Price, Cost and Margin of Alnylam Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Arrowhead
Tab Sales Revenue, Volume, Price, Cost and Margin of Dicerna Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of Mirna Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Quark Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of RXi Pharmaceuticals
Tab Sales Revenue, Volume, Price, Cost and Margin of miRagen Therapeutics
Tab Sales Revenue, Volume, Price, Cost and Margin of Gradalis
Tab Sales Revenue, Volume, Price, Cost and Margin of Sirnaomics
Tab Market Price by Region
Tab Market Price by Manufacturers
Tab Market Price by Application
Tab Price by SUK (Popular Goods on the Market)
LIST OF FIGURES
Fig Global RNAi for Therapeutic Market Size and CAGR 2011-2017 (Value)
Fig Global RNAi for Therapeutic Market Size and CAGR 2011-2017 (Volume)
Fig Global RNAi for Therapeutic Market Forecast and CAGR 2018-2025 (Value)
Fig Global RNAi for Therapeutic Market Forecast and CAGR 2018-2025 (Volume)
Fig Cancer Market Size and CAGR 2011-2017 (Value)
Fig Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Cardiovascular Market Size and CAGR 2011-2017 (Value)
Fig Cardiovascular Market Size and CAGR 2011-2017 (Volume)
Fig Cardiovascular Market Forecast and CAGR 2018-2025 (Value)
Fig Cardiovascular Market Forecast and CAGR 2018-2025 (Volume)
Fig HBV Market Size and CAGR 2011-2017 (Value)
Fig HBV Market Size and CAGR 2011-2017 (Volume)
Fig HBV Market Forecast and CAGR 2018-2025 (Value)
Fig HBV Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Market Size and CAGR 2011-2017 (Value)
Fig Other Market Size and CAGR 2011-2017 (Volume)
Fig Other Market Forecast and CAGR 2018-2025 (Value)
Fig Other Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
Fig Global RNAi for Therapeutic Market Size and CAGR 2011-2017 (Value)
Fig Global RNAi for Therapeutic Market Size and CAGR 2011-2017 (Volume)
Fig Global RNAi for Therapeutic Market Forecast and CAGR 2018-2025 (Value)
Fig Global RNAi for Therapeutic Market Forecast and CAGR 2018-2025 (Volume)
Fig Cancer Market Size and CAGR 2011-2017 (Value)
Fig Cancer Market Size and CAGR 2011-2017 (Volume)
Fig Cancer Market Forecast and CAGR 2018-2025 (Value)
Fig Cancer Market Forecast and CAGR 2018-2025 (Volume)
Fig Cardiovascular Market Size and CAGR 2011-2017 (Value)
Fig Cardiovascular Market Size and CAGR 2011-2017 (Volume)
Fig Cardiovascular Market Forecast and CAGR 2018-2025 (Value)
Fig Cardiovascular Market Forecast and CAGR 2018-2025 (Volume)
Fig HBV Market Size and CAGR 2011-2017 (Value)
Fig HBV Market Size and CAGR 2011-2017 (Volume)
Fig HBV Market Forecast and CAGR 2018-2025 (Value)
Fig HBV Market Forecast and CAGR 2018-2025 (Volume)
Fig Other Market Size and CAGR 2011-2017 (Value)
Fig Other Market Size and CAGR 2011-2017 (Volume)
Fig Other Market Forecast and CAGR 2018-2025 (Value)
Fig Other Market Forecast and CAGR 2018-2025 (Volume)
Fig Global Market Price 2011-2017
Fig Global Market Price 2018-2025
